41.20000 EUR
4.2
9.25%
Last update Dec 16, 5:07 PM CET
Market closed
Day range
41.20000
41.20000
Previous close
45.40000
Open
41.20000
Access this stock data via API
Subscribe
Nektar Therapeutics Inc.
41.20
4.20
9.25%

Statistics

Valuation metrics
Market cap
0
Enterprise value
49.71M
Trailing P/E (ttm)
-4.74
Forward P/E
PEG ratio
0.15
Price/Sales (ttm)
0
Price/Book (mrq)
9.17
Enterprise Value/Revenue
0.59
Enterprise Value/EBITDA
-0.52
Overview
Shares outstanding
19.65M
Float
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
25
Average volume (90 days)
12
Price summary
52-Week low
6.39
52-Week high
56.50
52-Week change
68.09 1,065.6%
Beta
50-Day moving average
49.71
200-Day moving average
26.09
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
68.82%
Operating margin
-92.54%
Operational effectiveness
Return on assets
-39.15%
Return on equity
-195.86%
Income statement
Revenue (ttm)
83.91M
Revenue per share (ttm)
7.18
Quarterly revenue growth (yoy)
5.50%
Gross profit (ttm)
57.75M
EBITDA
0
Net income to common (ttm)
-101.41M
Diluted EPS (ttm)
-8.70
Quarterly earnings growth (yoy)
-51.81%
Balance sheet
Total cash (mrq)
0
Total cash per share (mrq)
Total debt (mrq)
78.36M
Total Debt/Equity (mrq)
1.08
Current ratio (mrq)
424.11%
Book value per share (mrq)
4.49
Cash flow
Cash flow statement
-124.54M
Levered free cash flow (LFCF)
-101.41M
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 5 hours 23 minutes

02:36
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).